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Hypoxia is a characteristic of the tumor microenvironment and is known to contribute 
to tumor progression and treatment resistance. Hypoxia-inducible factor (HIF) dimeric 
transcription factors control the cellular response to reduced oxygenation by regulating 
the expression of genes involved in metabolic adaptation, cell motility, and survival. 
Alterations in mitochondrial metabolism are not only a downstream consequence of HIF-
signaling but mitochondria reciprocally regulate HIF signaling through multiple means, 
including oxygen consumption, metabolic intermediates, and reactive oxygen species 
generation. CHCHD4 is a redox-sensitive mitochondrial protein, which we previously 
identified and showed to be a novel regulator of HIF and hypoxia responses in tumors. 
Elevated expression of CHCHD4 in human tumors correlates with the hypoxia gene 
signature, disease progression, and poor patient survival. Here, we show that either 
long-term (72 h) exposure to hypoxia (1% O2) or elevated expression of CHCHD4 in 
tumor cells in normoxia leads to perinuclear accumulation of mitochondria, which is 
dependent on the expression of HIF-1α. Furthermore, we show that CHCHD4 is required 
for perinuclear localization of mitochondria and HIF activation in response to long-term 
hypoxia. Mutation of the functionally important highly conserved cysteines within the 
Cys-Pro-Cys motif of CHCHD4 or inhibition of complex IV activity (by sodium azide) 
redistributes mitochondria from the perinuclear region toward the periphery of the cell and 
blocks HIF activation. Finally, we show that CHCHD4-mediated perinuclear localization 
of mitochondria is associated with increased intracellular hypoxia within the perinuclear 
region and constitutive basal HIF activation in normoxia. Our study demonstrates that 
the intracellular distribution of the mitochondrial network is an important feature of the 
cellular response to hypoxia, contributing to hypoxic signaling via HIF activation and 
regulated by way of the cross talk between CHCHD4 and HIF-1α.
Keywords: hypoxia, hypoxia-inducible factor-1α, mitochondria, mitochondrial localization, perinuclear, coiled-coil 
helix coiled-coil helix domain containing 4
inTrODUcTiOn
Low oxygenation (hypoxia) is a key feature of most human tumors and is associated with tumor 
progression and treatment resistance. Hypoxia activates a transcriptional program via the hypoxia-
inducible factor (HIF) dimeric transcription factors, enabling tumor cells to metabolically adapt, 
survive, and metastasize. As the major sites of oxygen consumption within the cell, mitochondria 
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control basal intracellular oxygenation (1) and cell metabolism 
(2). Mitochondrial reactive oxygen species (ROS) production 
and respiratory chain function regulate HIF activation (3). In 
addition, hypoxia and HIF transcriptional targets influence 
mitochondrial function (4–6). Of particular interest is the recent 
evidence showing that hypoxia leads to changes in mitochondrial 
morphology (7) and intracellular distribution (8) that are linked 
to reduced sensitivity to killing by cytotoxic agents (7) and HIF 
activation (8), respectively. However, the precise mitochondrial 
molecular mechanisms involved in tumor cell hypoxia responses 
that contribute to tumor progression and treatment resistance are 
not known.
Previously, we discovered that the redox-sensitive 
mitochondrial protein coiled-coil helix coiled-coil helix 
(CHCH) domain containing 4 (CHCHD4) controls basal 
cellular oxygen consumption rate (OCR), metabolic adaptive 
responses, HIF activation, and hypoxia signaling in tumor 
cells (9). We found that CHCHD4 overexpression in human 
cancers correlates with the hypoxia gene signature and is 
associated with tumor progression and poor patient survival. 
CHCHD4 (known as Mia40 in yeast) is a key component of 
the disulfide relay system (DRS) within the mitochondrial 
intermembrane space (IMS) (9). As an oxidoreductase and 
part of the DRS, CHCHD4 functions to import and introduce 
disulfide bonds into proteins containing highly evolutionarily 
conserved cysteine motifs [e.g., twin-(CX3C) or twin-(CX9C) 
motif] that are essential for mitochondrial function (9–12). 
In doing so, electrons are generated and transferred via the 
DRS to cytochrome c and complex IV (the molecular oxygen 
accepting complex) of the respiratory chain (13). CHCHD4 
mitochondrial localization and import function are dependent 
on the highly evolutionarily conserved cysteines within the 
CHCH domain and redox-sensitive Cys-Pro-Cys (CPC) motif 
(9, 10). CHCHD4 substrates are involved in various aspects 
of mitochondrial biology, including the assembly and activity 
of respiratory chain complexes, modeling of the cristae, lipid 
biosynthesis, and protein import into the matrix [reviewed in 
Ref. (12)].
In this study, we evaluate the contribution of CHCHD4 
mitochondrial function to HIF signaling in tumor cells. We 
show that increased expression of CHCHD4 in tumor cells leads 
to intracellular hypoxia and constitutive activation of HIF. We 
show that either long-term exposure of cells to hypoxia (72 h) 
or increased expression of CHCHD4 in tumor cells leads to 
(i) the redistribution of the mitochondria to the perinuclear region 
of the cell, (ii) HIF-1α stabilization, and (iii) the upregulation of 
HIF targets. Hypoxic perinuclear localization of mitochondria 
is dependent on CHCHD4. CHCHD4-mediated perinuclear 
localization of mitochondria in normoxia correlates with elevated 
intracellular hypoxia and requires the highly conserved cysteines 
within the CPC motif. Finally, we show that both hypoxic and 
CHCHD4-mediated perinuclear accumulation of mitochondria 
is dependent on HIF-1α expression. Our data highlight for the 
first time the importance of CHCHD4 in regulating mitochon-
drial subcellular localization, intracellular oxygenation, and HIF 
activation in tumor cells.
resUlTs
hypoxia induces Perinuclear localization 
of Mitochondria
Mitochondria respond to exogenous hypoxia in numerous ways 
including regulating oxygen consumption and respiratory chain 
efficiency (5) and controlling metabolic signaling pathways (14) 
in order to maintain cellular energy homeostasis and cell viabil-
ity when oxygen is limiting. In addition, other mitochondrial 
parameters such as mitochondrial dynamics (7, 15) and subcel-
lular localization are also known to be influenced by hypoxia 
(8, 16) via mechanisms that are not yet understood. To explore 
the cross talk between mitochondria and the hypoxia (HIF) 
response, we first set out to investigate the effect of hypoxia on 
mitochondrial morphology and intracellular distribution of 
the mitochondrial network over a prolonged time course. We 
found that 72 h of exposure to 1% O2, but not 24 or 48 h, led 
to a visible redistribution of the mitochondrial network from 
the periphery of the cell to the perinuclear region, in both HeLa 
(Figures 1A,B) and in human U2OS osteosarcoma (U2OS-HRE-
luc) cells (Figures  1C,D). U2OS-HRE-luc cells were generated 
by us previously (17). Digital analysis of the distribution of mito-
chondrial fluorescence across cytoplasmic segments confirmed 
a small but significant redistribution of the mitochondria to the 
perinucleus in HeLa (Figure 1B) and U2OS (Figure 1D) cells. 
HIF-1α protein stabilization over this hypoxia time course was 
strongest at 24 h in U2OS cells and declined by 48 h, but HIF 
was still transcriptionally active at 72 h, as indicated by sustained 
upregulated expression of the HIF targets BNIP3 (Figures 1E,F) 
and PHD3 (Figure 1F).
chchD4 regulates Perinuclear 
localization of Mitochondria and 
Mitochondrial Morphology
Recently, we identified the mitochondrial protein CHCHD4 
as a critical regulator of HIF-1α stabilization and signaling 
in hypoxia through its effects on mitochondrial function (9). 
For this reason, we next investigated whether CHCHD4 was 
required for the hypoxic redistribution of mitochondria to the 
perinucleus. Depletion of CHCHD4 using two independent 
siRNAs significantly reduced the perinuclear accumulation of 
the mitochondrial network in cells incubated for 72 h at 1% O2 
(Figures  2A,B) resulting in a more peripheral distribution of 
mitochondria (Figure 2C). Consistent with our previous study 
(9), CHCHD4 knockdown also blocked the hypoxic stabilization 
of HIF-1α protein and the transcriptional upregulation of HIF 
targets, including BNIP3 (Figure  2D) and CA9 (Figure  2E). 
These data suggest that CHCHD4 expression is required for the 
perinuclear redistribution of the mitochondria in response to 
hypoxia and also indicate that there may be a HIF-dependent 
aspect to this phenomenon.
Previously, we discovered that CHCHD4 regulates HIF-
1α protein stability and HIF activity in both loss and gain of 
function systems (9). Therefore, we next investigated whether 
the mitochondrial network was distributed differently in 
FigUre 1 | hypoxia induces perinuclear localization of mitochondria. (a) Images of immunostaining analyses of HeLa cells incubated in normoxia or hypoxia 
(1% O2) for 72 h. Cells were immunostained for COXIV (mitochondria, green) and α-tubulin (cytoskeleton, red). Nuclei were stained with DAPI (blue). Scale 
bar = 40 µm. (B) Graph shows the perinuclear proportion of mitochondrial fluorescence per cell, analyzed from cells described in (a) (10 fields of view per 
condition). *p < 0.05. (c) Images of U2OS cells incubated in normoxia or hypoxia (1% O2) for the indicated times. Cells were immunostained as in (a). Scale 
bar = 40 µm. (D) Graph shows the perinuclear proportion of mitochondrial fluorescence per cell, analyzed from cells described in (c) (10 fields of view per 
condition). n = 3; n.s., not significant; ***p < 0.001. (e) Western blots show hypoxia-inducible factor (HIF)-1α and BNIP3 protein levels in U2OS cells described in 
(c). β-actin was used as a load control. (F) Graph shows expression of BNIP3 and PHD3 analyzed by QPCR using total RNA isolated from U2OS cells incubated  
in normoxia (0 h) or hypoxia (1% O2) for 24, 48, and 72 h. *p < 0.05, **p < 0.01.
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FigUre 2 | chchD4 is required for perinuclear localization of mitochondria in hypoxia. (a) Images of immunostaining analyses of U2OS cells incubated in 
normoxia or hypoxia (1% O2) for 72 h. Cells were untreated (control) or transfected with siRNAs targeting CHCHD4 [siRNA(1) and (2)]. Cells were immunostained for 
COXIV (mitochondria, green) and α-tubulin (cytoskeleton, red). Nuclei were stained with DAPI (blue). Scale bar = 40 µm. (B,c) Graphs show the perinuclear (B) or 
peripheral (c) proportion of mitochondrial fluorescence per cell, analyzed from cells described in (a) (10 fields of view per condition). n = 3; ***p < 0.001. (D) Western 
blots show hypoxia-inducible factor (HIF)-1α, BNIP3, and CHCHD4 protein levels in U2OS cells described in (a). β-actin was used as a load control. (e) Graphs show 
expression of CA9 and CHCHD4 analyzed by QPCR using total RNA isolated from U2OS cells incubated in normoxia or hypoxia (1% O2) for 72 h. Cells were 
untreated (NT), treated with non-silencing control (control siRNA) or siRNAs targeting CHCHD4 [siRNA(1) and (2)]. Mean ± SD. n = 2. n.s., not significant; **p < 0.01.
4
Thomas et al. CHCHD4 Controls Mitochondrial Localization
Frontiers in Oncology | www.frontiersin.org April 2017 | Volume 7 | Article 71
FigUre 3 | chchD4 regulates perinuclear localization of mitochondria and mitochondrial morphology. (a) Images of immunostaining analysis of  
U2OS cells (control), CHCHD4 wild-type (WT)-expressing (WT.cl1) cells, or CHCHD4 (C66A/C68A)-expressing cells. Cells were immunostained for COXIV 
(mitochondria, green) and α-tubulin (cytoskeleton, red). Nuclei were stained with DAPI (blue). Scale bar = 40 µm. (B) Graph shows the perinuclear proportion of 
mitochondrial fluorescence per cell, analyzed from cells described in (a) (10 fields of view per condition). n = 3; n.s., not significant, ***p < 0.001. (c) Western blots 
show exogenously expressed CHCHD4 protein levels (immunoblotted for the myc-epitope tag) in cells described in (a). β-actin was used as a load control.  
(D) Electron microscope images of cells described in (a). Scale bar = 2 µm. (e) Graph shows % mitochondria >1 µm/cell from images described in (D). 
n = 25 cells, ***p < 0.001.
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independent clonal U2OS cell lines stably expressing wild-type 
(WT) CHCHD4 [CHCHD4 (WT)-expressing cells, clones 
WT.cl1 or WT.cl3]. Under normoxic conditions, the localization 
of the mitochondrial network in CHCHD4 (WT)-expressing 
cells was significantly more perinuclear compared with control 
cells (Figures 3A–C). However, stable expression of a mutant 
form of CHCHD4, in which the highly conserved cysteines of 
the CPC motif have been changed to alanines (C66A/C68A) (9), 
did not lead to perinuclear accumulation of the mitochondrial 
network (Figures 3A–C). We (9) and others (10) have previously 
shown that the highly conserved cysteines within CHCHD4 
are required for its mitochondrial localization (9) and import 
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function (10). These data suggest that the effects of CHCHD4 
on mitochondrial subcellular distribution are dependent on its 
mitochondrial localization and import function. Interestingly, 
in both primary human and yeast cells harboring mutations in 
the sulfhydryl oxidase GFER (Erv1 in yeast), which is essential 
for the redox activity of CHCHD4 (Mia40 in yeast), the mito-
chondria show significant changes in both their distribution 
and morphology (18, 19).
Changes in mitochondrial dynamics (fission and fusion) are 
also known to underlie changes in the distribution of the mito-
chondrial network and have been detected under both short- (20) 
and long-term exposure to hypoxia (7). Using electron microscopy, 
we confirmed the perinuclear localization of the mitochondria in 
CHCHD4 (WT)-expressing cells and observed larger mitochon-
dria (>1 μm in diameter) compared with control cells, suggest-
ing that elevated CHCHD4 expression causes increased fusion 
of the mitochondrial network (Figures 3D,E). Consistently, we 
observed reduced expression of the mitochondrial fission protein 
dynamin-related protein 1 (DRP-1) (21) in CHCHD4 (WT)-
expressing cells (data not shown), which is a protein previously 
shown to be involved in regulating perinuclear localization of 
mitochondria (15). Conversely, in CHCHD4 (C66A/C68A)-
expressing cells, we observed a significantly reduced number of 
larger mitochondria (>1 μm in diameter) compared to control 
cells, suggesting a more fragmented phenotype, similar to that 
described in GFER mutant cells (18).
elevated chchD4 expression causes 
localized intracellular hypoxia within the 
Perinuclear region and constitutive hiF 
activation
It has been shown that the perinuclear accumulation of the 
mitochondria after short-term exposure to hypoxia is required 
for the efficient delivery of mitochondrial ROS to the (nuclear) 
promoters of key HIF target genes such as VEGF. We (9) and 
others (22) have proposed that mitochondria are responsible 
for the generation of intracellular oxygen gradients and are 
associated with local regions of reduced oxygenation within the 
cell. Furthermore, previously, we have discovered that elevated 
expression of CHCHD4 in tumor cells leads to increased OCR 
(9). Therefore, we hypothesized that CHCHD4-mediated 
perinuclear localization of mitochondria may lead to increased 
intracellular hypoxia within the perinuclear region of the cell. 
To investigate this, we used the hypoxia-marker pimonidazole 
(23) and immunofluorescence microscopy. Notably, pimo-
nidazole adduct formation is oxygen-dependent and occurs 
independently of changes in pyridine nucleotide redox state (i.e., 
NADP/H) (24). As anticipated, in CHCHD4 (WT)-expressing 
cells, we observed increased pimonidazole staining co-localized 
with mitochondria within the perinuclear region of the cell in 
normoxia (Figure  4A). We confirmed the elevated perinuclear 
hypoxia in CHCHD4 (WT)-expressing cells using a second fluo-
rescent hypoxia marker, HypoxiTRAK, by live cell imaging (data 
not shown). Concurrently, we observed significantly upregulated 
expression of the HIF-target gene transcripts, CA9 and BNIP3 in 
the CHCHD4 (WT)-expressing U2OS cells compared to control 
cells (Figure 4B), indicating above basal HIF-signaling in these 
cells. Interestingly, we have discovered previously that CHCHD4-
mediated enhanced HIF-1α protein stability and HIF activation is 
sensitive to inhibition by the complex IV inhibitor, sodium azide 
(9). Therefore, next, we assessed whether CHCHD4-mediated 
perinuclear localization of mitochondria was also affected by 
sodium azide treatment. Indeed, we found that sodium azide 
inhibited complex IV activity (data not shown) and significantly 
reduced the perinuclear localization of mitochondria (Figure 4C) 
and associated intracellular hypoxia (data not shown) in the 
CHCHD4 (WT)-expressing cells. Collectively our data suggest 
that CHCHD4-mediated perinuclear accumulation of mitochon-
dria is capable of generating associated localized areas of intracel-
lular hypoxia within the perinuclear region of the cell that are 
sufficient to lead to HIF transcriptional activation in normoxia. 
Furthermore, these effects are dependent on respiratory chain 
function (at least in part via complex IV).
Perinuclear accumulation of Mitochondria 
is hiF-1α-Dependent
The HIF transcription factor family constitute the major 
molecular regulators of the cellular response to hypoxia 
(25, 26) and are known to upregulate the expression of proteins 
involved in mitochondrial morphology and distribution (16). 
Therefore, next, we investigated whether perinuclear redistri-
bution of mitochondria in response to prolonged hypoxia was 
dependent on HIF-1α expression. Interestingly, we found that 
siRNA-mediated depletion of HIF-1α blocked the perinuclear 
accumulation of mitochondria in U2OS cells incubated for 72 h 
in 1% O2 (Figures  5A–C). HIF-1α knockdown also blocked 
hy poxic upregulation of the HIF transcriptional target BNIP3 
(Figure 5C). Furthermore, depletion of HIF-1α using two inde-
pendent siRNAs reversed the perinuclear accumulation of mito-
chondria in CHCHD4 (WT)-expressing cells (Figures  6A,B). 
However, we observed no significant effect of HIF-1α siRNA 
knockdown on the distribution of mitochondria in control cells 
(Figures 6A,B), despite significant knockdown of HIF1A expres-
sion (Figure 6C).
Our data highlight CHCHD4 as a critical regulator of mito-
chondrial distribution and morphology. Perinuclear accumula-
tion of mitochondria in response to hypoxia or elevated CHCHD4 
is associated with increased intracellular hypoxia within the 
perinuclear region and elevated HIF-1α stabilization and HIF 
transcriptional activation. Taken together, our study indicates 
that CHCHD4 can control the distribution of the mitochondrial 
network in tumor cells through its role in regulating respiratory 
chain function, intracellular oxygenation, and HIF activation.
MaTerials anD MeThODs
cell culture
Human U2OS osteosarcoma (U2OS-HRE-luc) cells have been 
described by us previously (17) and stably express a luciferase 
reporter construct under the control of a hypoxia response 
element, allowing us to monitor HIF/HRE activity alongside 
measuring mitochondrial endpoints. U2OS osteosarcoma 
FigUre 4 | elevated chchD4 expression causes localized intracellular hypoxia within the perinuclear region and constitutive hypoxia-inducible 
factor activation. (a) Images of immunostaining of U2OS cells (control) and CHCHD4 wild-type (WT)-expressing cells (clones WT.cl1 and WT.cl3) incubated with 
pimonidazole for 2 h. Cells were immunostained for pimonidazole (green) and ATP5B (mitochondria, red). Nuclei stained with DAPI (blue). Scale bar = 40 µm.  
(B) Graph shows expression of BNIP3 and CA9 analyzed by QPCR using total RNA isolated from cells described in (a). Mean ± SD. *p < 0.05. (c) Graph shows 
the perinuclear proportion of mitochondrial fluorescence per cell, analyzed from cells described in (a), after treatment without (−) or with (+) sodium azide  
(azide, 5 mM) for 16 h (10 fields of view per condition). n = 3; ***p < 0.001, *p < 0.05.
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(U2OS-HRE-luc) cells were used to generate stable independent 
clonal cell lines (WT.cl1 and WT.cl3)-expressing CHCHD4.1 
cDNA (CHCHD4 (WT)-expressing cells) or CHCHD4-C66A/
C668A cDNA (CHCHD4 (C66A/C68A)-expressing cells) by 
puromycin selection using constructs we have described previ-
ously (9). HeLa cells were purchased from ATCC. All cell lines 
were maintained in Dulbecco’s modified eagle medium contain-
ing glucose (4.5 g/L) (Life Technologies) and supplemented with 
10% fetal calf serum (FCS, SeraLabs), penicillin (100  IU/mL), 
streptomycin (100 µg/mL), and glutamine (6 mM), all purchased 
from Life Technologies. Cell lines used were authenticated 
and routinely confirmed to be negative for any Mycoplasma 
FigUre 5 | hypoxia-inducible factor (hiF)-1α knockdown reverses 
hypoxia-induced perinuclear localization of mitochondria.  
(a) Images of immunostaining of U2OS cells incubated in normoxia or 
hypoxia (1% O2) for 72 h. Cells were untreated (control) or transfected with 
siRNA targeting HIF1A (HIF-1α siRNA). Cells were immunostained for 
COXIV (mitochondria, green), and α-tubulin (cytoskeleton, red). Nuclei were 
stained with DAPI (blue). Scale bar = 40 µm. (B) Graph shows the 
perinuclear proportion of mitochondrial fluorescence per cell, analyzed 
from cells described in (a) (10 fields of view per condition). n = 3; 
***p < 0.001. (c) Western blots show HIF-1α and BNIP3 protein levels in 
U2OS cells untreated (NT), or transfected with a non-silencing control 
(control siRNA) or siRNA targeting HIF1A (HIF-1α siRNA). Cells were 
incubated in normoxia or hypoxia (1% O2) for 72 h. β-actin was used as a 
load control.
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contamination. Hypoxia was achieved by incubating cells in 
1% O2, 5% CO2, and 94% N2 in a Ruskinn SCI-tive workstation, 
without agitation.
antibodies and reagents
The rabbit polyclonal CHCHD4 and rabbit polyclonal BNIP3 
antibodies were purchased from Cambridge Biosciences. The 
mouse monoclonal HIF-1α antibody was purchased from BD 
Biosciences. The mouse monoclonal β-actin and rabbit polyclonal 
ATP5B antibodies were purchased from Abcam. The mouse mon-
oclonal anti-myc (9B11) and rabbit monoclonal COXIV (3E11) 
antibodies were purchased from Cell Signaling Technology. The 
mouse monoclonal anti-pimonidazole antibody was purchased 
from HypoxyProbe, Inc. The donkey anti-rabbit and anti-mouse 
horseradish peroxidase-linked secondary antibodies were 
purchased from VWR. Sodium azide was purchased from Sigma-
Aldrich and used at 5 mM for 16 h in order to optimally block HIF-
1α protein levels without significantly affecting cell viability. DAPI 
solution (10 mg/mL) was purchased from Cambridge Biosciences. 
Pimonidazole (200 mM) was purchased from HypoxyProbe, Inc.
immunofluorescent Microscopy
Cells were seeded onto 13 mm ⌀ coverslips, and after treatment, 
were fixed in either 4% paraformaldehyde (PFA) for 15 min (for 
assessment of intracellular hypoxia by pimonidazole staining) 
or 100% ice-cold methanol overnight (for assessment of the 
mitochondrial distribution by COXIV or ATP5B). Notably, 
we found that COXIV and ATP5B total protein levels in cells 
were not significantly affected by either prolonged exposure to 
hypoxia (1% O2) or stable increased expression of CHCHD4 
and as such, we deemed these mitochondrial proteins as suitable 
markers for immunostaining mitochondria in the experiments 
described in this study. For PFA fixed samples, cells were washed 
and permeabilized with a 0.5% Triton-X solution for 10 min, 
then washed with phosphate-buffered saline. Immunostaining 
was carried out using primary antibodies followed by fluores-
cently labeled secondary antibodies (anti-mouse Alexa 568 
and anti-rabbit Alexa 488, Life Technologies) as well as DAPI. 
All cell imaging was carried out using a DMI4000 B inverted 
microscope (Leica).
Mitochondrial Distribution analysis
Mitochondrial distribution analyses was carried out using Cell 
Profiler Image analysis software (27), and a custom image analysis 
pipeline was applied to each data set, as follows: images were 
loaded, and blue, green, and red channels were split into separate 
greyscale images and named “nuclei,” “mitochondria,” and “cell,” 
respectively. Individual, whole DAPI-stained (blue) fluorescent 
nuclei were identified as objects between 50 and 450 pixel units 
in diameter. Cell boundaries were identified using anti-α-tubulin 
(red) fluorescence, with Ridler–Calvard thresholding adopted 
to distinguish between cell edges. Only images of whole, entire 
nuclei, and/or whole entire cells were included. Nuclei or cells with 
their boundaries touching the edge of the image were excluded. 
Nuclear (blue) fluorescence was subtracted from the associated 
cell fluorescence with the resulting fluorescent shape identified as 
the cytoplasmic compartment. Each cytoplasmic compartment 
was divided into five equally spaced concentric rings (to control 
for different cell size), starting from the boundary of the nucleus. 
The mitochondrial (green) fluorescence intensity was measured 
in each concentric ring and provided as a fraction of the total 
cytoplasmic compartment fluorescence per cell. The sum of the 
two concentric areas closest to the nuclei was taken as the perinu-
clear region, while the two outermost concentric areas were taken 
FigUre 6 | hypoxia-inducible factor (hiF)-1α knockdown reverses chchD4-induced perinuclear localization of mitochondria. (a) Images show control 
U2OS cells (control) and CHCHD4 (WT)-expressing cells (WT.cl1), which were untreated (NT) or transfected with siRNAs targeting HIF1A [HIF-1α siRNA (1) and (2)]. 
Cells were immunostained for COXIV (mitochondria, green) and α-tubulin (cytoskeleton, red). Nuclei were stained with DAPI (blue). Scale bar = 50 µm. (B) Graphs 
show the perinuclear proportion of mitochondrial fluorescence per cell, analyzed from cells described in (a) [10 fields of view for each control cells (left graph), and 
CHCHD4 WT-expressing cells (WT.cl1, right graph)]. n = 3; n.s., not significant; ***p < 0.001. (c) Graph shows expression of HIF1A analyzed by QPCR using total 
RNA isolated from cells described in (a). Mean ± SD. n = 3. n.s., not significant; **p < 0.01.
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as the peripheral region. At least 10 fields of view were analyzed 
per condition, per experiment, and all data points expressed with 
mean indicated (solid black bar).
electron Microscopy
Cells were seeded onto glass coverslips (ø 13 mm, VWR) and fixed 
in 2% PFA and 1.5% glutaraldehyde in 0.1 M cacodylate buffer. 
Samples were post-fixed in 1% OsO4 (osmium tetraoxide) and 
1.5% potassium ferrocyanide [K4Fe (CN)6] in 0.1 M cacodylate 
buffer. Samples were dehydrated using a graded ethanol–water 
series, cleared in propylene oxide, and infiltrated with agar-100 
resin. Ultrathin sections were cut and collected on 300-mesh grids 
and stained with lead citrate. Sections were viewed using a Joel 
1010 transition electron microscope and images were recorded 
using a Gatan Orius CDD camera. Mitochondrial section diam-
eter was determined relative to the scale bar, and mitochondria 
grouped above and below 1 µm diameter. At least 20 fields of view 
were analyzed per condition.
gene silencing
Non-silencing siRNA duplexes (universal negative control #1) and 
custom designed siRNA duplexes were purchased from Sigma-
Aldrich and transfected into sub-confluent cells using HiPerfect 
transfection reagent (QIAGEN) according to the manufacturer’s 
instructions. The target sequences for CHCHD4 were 5′-GAGG 
AAACGTTGTGAATTA-3′ (siRNA(1)) and 5′-AAGATTTGGAC 
CCTTCCATTC-3′ (siRNA(2)). The target sequences for HIF1A  
were 5′-TACGTTGTGAGTGGTATTATT-3′ (siRNA(1)) and 
5′-TAGA AGGTATGTGGCATTTAT-3′ (siRNA(2)).
gene expression analysis
Total RNA samples were isolated using the GeneElute kit 
and protocol (Sigma-Aldrich). cDNA synthesis was carried 
out using the qScript synthesis kit and protocol (Quantabio). 
mRNA expression was measured by quantitative (Q)PCR using 
SYBR Green Mastermix (Eurogentec Ltd.) and the DNA Engine 
Opticon 2 system (BioRad). The QPCR primer sequences were 
as follows: CHCHD4_F 5′-GAGCTGAGGAAGGGAAGGAT-3′, 
CHCHD4_R 5′-AATCCATGCTCCTCGTATGG-3′; HIF1A_F 
5′-TCCAAGAAGCCCTAACGTGT-3′, HIF1A_R 5′-TGA TCGTC T 
GGCTGCTGTAA-3′; CA9_F5′-GCCGCCTTTCTGGAGGA-3′, 
CA9_R 5′-TCTTCCAAGCGAGACAGCAA-3′; BNIP3_F 5′-GAT 
ATGGGATTGGTCAAGTCG-3′, BNIP3_R 5′-CGCTCGTG 
TTCCTCATGCT; ACTB_F 5′-CCCAGAGCAAGAGAGG-R′, 
ACTB_R 5′-GTCCAGACGCAGGATG.
statistics
Values are expressed as mean ± SD unless otherwise stated and 
statistical significance was determined by a 2-tailed unpaired 
Student’s t-test, with significance set at p < 0.05.
DiscUssiOn
Mitochondria are organelles that exist in dynamic interrelated 
forms within a cellular mitochondrial network (28). It is now 
becoming clear that as such, mitochondria can influence many 
cellular processes and communicate with other organelles and 
intracellular machinery through changes in mitochondrial 
dynamics (fission and fusion), subcellular localization and mor-
phology (29). As the major sites of oxygen consumption within 
the cell, precisely how changes in intracellular oxygenation affect 
mitochondrial behavior is of particular interest since hypoxia 
underlies the pathology of a broad range of diseases including 
cancer.
Previous studies in various cell contexts have shown that 
hypoxia induces a redistribution of mitochondria to the perinu-
clear region of the cell (8, 15, 20, 30) and regulates mitochondrial 
dynamics and morphology, promoting enlarged, donut-like 
(also known as toroid) mitochondria (7, 20, 31). Here, we have 
demonstrated that hypoxia stimulates perinuclear accumulation 
of mitochondria in a CHCHD4-dependent manner.
We identified human CHCHD4 previously using a functional 
genomics approach and showed that it is crucial for regulat-
ing hypoxic (HIF) responses, basal OCR and metabolism in 
tumor cells (9). CHCHD4 is involved in importing and folding 
CHCH-domain-containing mitochondrial proteins as part of 
the DRS within the IMS (12) and in doing so, links the DRS 
to respiratory chain function. Interestingly, mutations in the 
sulfhydryl oxidase GFER (which recycles CHCHD4 within the 
DRS) are associated with changes in mitochondrial morphol-
ogy via changes in the mitochondrial recruitment of the fission 
protein DRP-1 (18).
We discovered previously that increased expression of 
CHCHD4 in human cancers (e.g., breast, glioma, and pancreatic) 
is associated with the upregulation of hypoxia regulated genes 
and poor patient survival (9). Here, we found that increased 
expression of CHCHD4 in tumor cells resulted in perinuclear 
accumulation of the mitochondria, intracellular hypoxia associ-
ated with the perinuclear region and constitutive HIF activation 
in normoxia. Hypoxia within the tumor microenvironment is a 
well-known driver of tumor cell invasiveness and resistance to 
therapy (32), mediated primarily through the upregulation of 
HIF targets that enable tumor cells to survive and metabolically 
adapt (25, 26). Mitochondria are uniquely placed to influence 
intracellular oxygenation and communicate to HIF. Indeed, the 
ability for mitochondria to localize within close proximity to the 
nucleus in response to hypoxia has been proposed to enable mito-
chondrial ROS to accumulate within the nucleus and enhance 
the transcription of genes such as VEGF through promoter 
oxidation (8). Our study describes for the first time that regional 
(perinuclear) intracellular hypoxia is associated with increased 
basal transcription of HIF target genes.
Interestingly, we found that perinuclear mitochondria in 
CHCHD4 (WT)-expressing cells could be redistributed toward 
the periphery of the cell by transient (siRNA) depletion of 
HIF-1α or by treatment with the complex IV inhibitor, sodium 
azide. Notably, we found that the intracellular hypoxia observed 
in CHCHD4 (WT)-expressing cells was reduced by sodium 
azide treatment, while depletion of HIF-1α had no significant 
effect (data not shown). Based on our findings we propose that 
CHCHD4’s upstream control of respiratory chain function and 
basal OCR (at complex IV) is important for regulating intra-
cellular oxygenation and HIF-1α signaling, while perinuclear 
localization of mitochondria is downstream.
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As well as HIF-1α, HIF-2α protein is also dynamically induced 
over time in hypoxia, and it will be important to establish what 
role, if any, HIF-2α might play in regulating mitochondrial 
distribution and morphology. Furthermore, the response to 
hypoxia includes HIF-dependent metabolic adaptations which 
involve substrate switching and the reprogramming of metabolic 
pathways to maintain energetic and biosynthetic homeostasis 
(33). Thus, the prolonged time-frame for perinuclear accumula-
tion of the mitochondria to occur in hypoxia (72 h) may reflect 
the metabolic and bioenergetic consequences of HIF activation. 
For example, in hypoxia, glucose consumption is elevated to 
support anaerobic ATP generation, while glutamine is diverted 
from the TCA cycle, and undergoes reductive carboxylation to 
support the production of lipids for membrane biosynthesis, both 
of which depend on HIF-1 signaling. Extended culture of cells 
in hypoxia is likely therefore to lead to the depletion of different 
metabolic substrates from, and accumulation of different meta-
bolic by-products (e.g., lactate) in the culture medium compared 
to cells cultured in normoxia. It has been shown that substrate 
starvation has significant effects on mitochondrial motility (34) 
and morphology (35), and these two parameters are known to be 
intimately linked to the bioenergetic status of the mitochondria. 
Therefore, it will be of interest to investigate whether metabolic 
substrate availability (increased or decreased) is able to affect 
perinuclear accumulation of the mitochondria in response to 
changes in intracellular oxygenation.
Understanding the molecular mechanisms underlying how 
tumors respond to hypoxia is of great importance both in devis-
ing prognostic tests and for identifying improved therapeutic 
strategies for cancer treatment. Indeed, recent studies have high-
lighted advances in imaging mitochondrial dynamics associated 
with hypoxia in tumors for potential use in diagnosis (36) or as a 
biomarker for response to therapy (37). Further work exploring 
CHCHD4’s role in regulating mitochondrial dynamics should 
reveal how CHCHD4 or specific CHCHD4 substrates control 
intracellular oxygenation, HIF signaling and the distribution of 
the mitochondrial network.
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